🔎 Trials Near Me

Gara Jalqabaatti › Astrocytoma › North Carolina › Durham

Qorannoo klinikaalii Astrocytoma Durham, NC keessatti

Qorannoo 6 Astrocytoma f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Targeted Pediatric High-Grade Glioma Therapy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Duke University Health System, Durham
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Health System, Durham
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • Duke Cancer Institute, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
  • Duke University Health System, Durham
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Namoota walitti qabaa jiraSadarkaa 2
  • Duke University Health System, Durham
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Namoota walitti qabaa jiraSadarkaa 1
  • Duke University, Durham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05879367

Qorannoo Astrocytoma magaalota biroo keessatti

Qorannoo biroo Durham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.